Abstract:The title compound, diisopropyl[(4-cyanopyrazol-3-ylamino)(2-hydroxylphenyl)methyl] phosphonate was synthesized by the addition reaction of diisopropyl phosphite and N-(4-cyanopyrazole-3-yl)-2-hydroxylphenyl-imine. Its structure was characterized by IR, H-1 NMR, elemental analysis and single-crystal X-ray diffraction. The crystal belongs to the triclinic system, space group P (1) over bar With a = 9.1840(13), b = 9.2278(13), c = 12.1952(17) angstrom, alpha = 93.846(2), beta = 90.947(2), gamma = 111.289(2)degrees, V = 959.9(3) angstrom(3), D-c = 1.309 g/cm(3), Z = 2, mu(MoKa) = 0.173, F(000) = 400; the final R = 0.0414 and wR = 0.1196 for 2985 observed reflections (I > 2 sigma(I)). The pyrazole and benzene moieties are approximately coplanar in each case. The dihedral angle between planes 1 and 2 is 82.99 degrees. The crystal structure is stabilized by three intermolecular hydrogen bonds of O(1)-H(1)center dot center dot center dot O(2), N(2)-H(2)center dot center dot center dot N(3) and N(2)-H(2)center dot center dot center dot O(1). Preliminary bioassay indicated that the title compound possessed antiviral activity to some extent.

(S)-2-[(2r,3s)-2-ammonio-3-hydroxy-3-(4-nitrophenyl)propanamido]-4-methy Lpentanoate Monohydrate

2-Amino-4-methylpyridinium 4-Aminobenzoate

(R)-Methioninium–(r)-mandelate–(r)-mandelic Acid (1/1/2)

Catena-Poly[[[(4-aminobenzoato-κn)aqua(2,2′-diamino-4,4′-bithiazole-κ2n,n′)nickel(ii)]-μ-4-aminobenzoato-κ2n:O] Monohydrate]

2-Ammonio-3-(4-nitro-phen-yl)propanoate Monohydrate.

1-(P-tolylsulfonyl)-l-proline Ethyl Ester

(4-Hydroxyphenyl)methanaminium 2-(4-Sulfanylphenyl)acetate

2-{N′-[3-(dimethylammonio)propyl]oxamido}benzoate

4-{2-[4-(Dimethylamino)phenyl]ethenyl}-1-methylpyridinium 2-amino-3,5-dimethylbenzenesulfonate monohydrate

(S)-N-(1-hydroxymethyl-2-methylpropyl)-2-methoxybenzamide

(1R,4as,10ar)-1,4A-dimethyl-n-[(morpholin-4-yl)carbothioyl]-7-(propan-2- Yl)-1,2,3,4,4a,9,10,10a-Octahydrophenanthrene-1-Carboxamide

N-(4-Ethoxyphenyl)-2-[(4-Ethoxyphenylcarbamoyl)Methoxy]Acetamide Monohydrate, A Supramolecular Chain Structure Formed by Hydrogen Bonds

(S)-1-[3,5-Bis(trifluoromethyl)phenyl]-N-methylethylamine–(R)-2-hydroxybutanedioic acid (1/1)

Dimethyl [Phenyl(pyridine-4-carboxamido)-methyl]phosphonate

(3S,4r)-3-ethyl-4-hydroxy-3-(3-methoxyphenyl)-1-methylazepanium (2R,3r)-2,3-bis(benzoyloxy)-3-carboxypropionate

N-[3-(Dimethylamino)propyl]-N&#8242;-(2-hydroxy-5-methylphenyl)oxamide

N-[3-(Dimethylamino)propyl]-N′-(2-hydroxy-5-methylphenyl)oxamide

(S)-1-[3,5-Bis(trifluoromethyl)phenyl]-N-methylethylamine-(R) -2-hydroxybutanedioic acid (1/1)

[Hydroxy(4-Pyridyl)methyl]phosphonic Acid Monohydrate

Synthesis, Bioactivity and Crystal Structure Analysis of Diisopropyl[(4-Cyanopyrazol-3-Ylamino)(2-Hydroxyl-Phenyl)Methyl]Phosphon Ate

Ethyl 5-Amino-1-(5-amino-3-methyl-1-phenyl-1h-pyrazol-4-ylcarbonyl)-3-methyl-1h-pyrazole-4-carboxylate

(S)-2-[(2r,3s)-2-ammonio-3-hydroxy-3-(4-nitrophenyl)propanamido]-4-methy Lpentanoate Monohydrate

2-Amino-4-methylpyridinium 4-Aminobenzoate

(R)-Methioninium–(r)-mandelate–(r)-mandelic Acid (1/1/2)

Catena-Poly[[[(4-aminobenzoato-κn)aqua(2,2′-diamino-4,4′-bithiazole-κ2n,n′)nickel(ii)]-μ-4-aminobenzoato-κ2n:O] Monohydrate]

2-Ammonio-3-(4-nitro-phen-yl)propanoate Monohydrate.

1-(P-tolylsulfonyl)-l-proline Ethyl Ester

(4-Hydroxyphenyl)methanaminium 2-(4-Sulfanylphenyl)acetate

2-{N′-[3-(dimethylammonio)propyl]oxamido}benzoate

4-{2-[4-(Dimethylamino)phenyl]ethenyl}-1-methylpyridinium 2-amino-3,5-dimethylbenzenesulfonate monohydrate

(S)-N-(1-hydroxymethyl-2-methylpropyl)-2-methoxybenzamide

(1R,4as,10ar)-1,4A-dimethyl-n-[(morpholin-4-yl)carbothioyl]-7-(propan-2- Yl)-1,2,3,4,4a,9,10,10a-Octahydrophenanthrene-1-Carboxamide

N-(4-Ethoxyphenyl)-2-[(4-Ethoxyphenylcarbamoyl)Methoxy]Acetamide Monohydrate, A Supramolecular Chain Structure Formed by Hydrogen Bonds

(S)-1-[3,5-Bis(trifluoromethyl)phenyl]-N-methylethylamine&#8211;(R)-2-hydroxybutanedioic acid (1/1)

Dimethyl [Phenyl(pyridine-4-carboxamido)-methyl]phosphonate

(3S,4r)-3-ethyl-4-hydroxy-3-(3-methoxyphenyl)-1-methylazepanium (2R,3r)-2,3-bis(benzoyloxy)-3-carboxypropionate

N-[3-(Dimethylamino)propyl]-N&amp;#8242;-(2-hydroxy-5-methylphenyl)oxamide

N-[3-(Dimethylamino)propyl]-N′-(2-hydroxy-5-methylphenyl)oxamide

(S)-1-[3,5-Bis(trifluoromethyl)phenyl]-N-methylethylamine-(R) -2-hydroxybutanedioic acid (1/1)

[Hydroxy(4-Pyridyl)methyl]phosphonic Acid Monohydrate

Synthesis, Bioactivity and Crystal Structure Analysis of Diisopropyl[(4-Cyanopyrazol-3-Ylamino)(2-Hydroxyl-Phenyl)Methyl]Phosphon Ate

Ethyl 5-Amino-1-(5-amino-3-methyl-1-phenyl-1h-pyrazol-4-ylcarbonyl)-3-methyl-1h-pyrazole-4-carboxylate

(S)-1-[3,5-Bis(trifluoromethyl)phenyl]-N-methylethylamine–(R)-2-hydroxybutanedioic acid (1/1)

N-[3-(Dimethylamino)propyl]-N′-(2-hydroxy-5-methylphenyl)oxamide